ONCE-WEEKLY TRANSCON® CNP (NAVEPEGRITIDE) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF ACHONDROPLASIA IN CHILDREN

Reuters · 2d ago

Please log in to view news